Annual report [Section 13 and 15(d), not S-K Item 405]

Cover

v3.26.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
May 29, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 000-21617    
Entity Registrant Name ProPhase Labs, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 23-2577138    
Entity Address, Address Line One 626 RXR Plaza    
Entity Address, Address Line Two 6th Floor    
Entity Address, City or Town Uniondale    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 11556    
City Area Code (516)    
Local Phone Number 989-0763    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 15,164,927
Entity Common Stock, Shares Outstanding   14,016,025  
Documents Incorporated by Reference
Portions of the Registrant’s definitive proxy statement relating to its 2026 annual meeting of stockholders (the “2026 Proxy Statement”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2026 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
    
Entity Central Index Key 0000868278    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false